Calbindin-D28K inhibits apoptosis in dopaminergic neurons by activation of the PI3-kinase-Akt signaling pathway

Neuroscience

Volumn 199, Issue , 2011, Pages 359-367

  Sun, S ^a   Li, F ^a   Gao, X ^a   Zhu, Y ^a   Chen, J ^a   Zhu, X ^a   Yuan, H ^a   Gao, D ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Calbindin D28K; Dopaminergic neuron; Parkinson's disease; PI 3K Akt signaling pathway

Indexed keywords

CALBINDIN; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDOPAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; WORTMANNIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXPRESSION VECTOR; GENETIC TRANSFECTION; INHIBITION KINETICS; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADRENERGIC AGENTS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL LINE; CELL SEPARATION; DOPAMINERGIC NEURONS; ENZYME ACTIVATION; ENZYME INHIBITORS; FLOW CYTOMETRY; MICE; OXIDOPAMINE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 83055176416     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.09.054     Document Type: Article

References (36)

1. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-1071.
2. Chard P.S., Jordán J., Marcuccilli C.J., Miller R.J., Leiden J.M., Roos R.P., Ghadge G.D. Regulation of excitatory transmission at hippocampal synapses by calbindin D28k. Proc Natl Acad Sci U S A 1995, 92:5144-5148.
3. Choi W.S., Lee E., Lim J., Oh Y.J. Calbindin-D28K prevents drug-induced dopaminergic neuronal death by inhibiting caspase and calpain activity. Biochem Biophys Res Commun 2008, 371:127-131.
4. Datta S.R., Brunet A., Greenberg M.E. PMID-10579998: a play in three Akts. Genes Dev 1999, 13:2905-2927.
5. German D.C., Manaye K.F., Sonsalla P.K., Brooks B.A. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells. Ann N Y Acad Sci 1992, 648:42-62.
6. Ghosh A., Roy A., Liu X., Kordower J.H., Mufson E.J., Hartley D.M., Ghosh S., Mosley R.L., Gendelman H.E., Pahan K. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A 2007, 104:18754-18759.
7. Goodman J.H., Wasterlain C.G., Massarweh W.F., Dean E., Sollas A.L., Sloviter R.S. Calbindin-D28k immunoreactivity and selective vulnerability to ischemia in the dentate gyrus of the developing rat. Brain Res 1993, 606:309-314.
8. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 1996, 274:1383-1835.
9. Gross M., Kumar R. Physiology and biochemistry of vitamin D-dependent calcium binding proteins. Am J Physiol 1990, 259:F195-F209.
10. Heese K., Inoue N., Sawada T. NF-kappaB regulates B-cell-derived nerve growth factor expression. Cell Mol Immunol 2006, 3:63-66.
11. Hunot S., Brugg B., Ricard D., Michel P.P., Muriel M.P., Ruberg M., Faucheux B.A., Agid Y., Hirsch E.C. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proc Natl Acad Sci U S A 1997, 94:7531-7536.
12. Iacopino A.M., Christakos S. Specific reduction of calcium-binding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci U S A 1990, 87:4078-4082.
13. Jeong S.J., Pise-Masison C.A., Radonovich M.F., Park H.U., Brady J.N. Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells. Oncogene 2005, 24:6719-6728.
14. Kojetin D.J., Venters R.A., Kordys D.R., Thompson R.J., Kumar R., Cavanagh J. Structure, binding interface and hydrophobic transitions of Ca2+-loaded calbindin-D(28k). Nat Struct Mol Biol 2006, 13:641-647.
15. Landfield P.W., Cadwallader-Neal L. Long-term treatment with calcitriol (1,25(OH)2 vit D3) retards a biomarker of hippocampal aging in rats. Neurobiol Aging 1998, 19:469-477.
16. Lavoie B., Parent A. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys. Neuroreport 1991, 2:601-604.
17. Liang C.L., Sinton C.M., Sonsalla P.K., German D.C. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration. Neurodegeneration 1996, 5:313-318.
18. Lin M.T., Chang C.C., Chen S.T., Chang H.L., Su J.L., Chau Y.P., Kuo M.L. Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation. Biol Chem 2004, 279:24015-24023.
19. Livolsi A., Busuttil V., Imbert V., Abraham R.T., Peyron J.F. Tyrosine phosphorylation-dependent activation of NF-kappaB. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Eur J Biochem 2001, 268:1508-1515.
20. Lutz W., Frank E.M., Craig T.A., Thompson R., Venters R.A., Kojetin D., Cavanagh J., Kumar R. Calbindin D28K interacts with Ran-binding protein M: identification of interacting domains by NMR spectroscopy. Biochem Biophys Res Commun 2003, 303:1186-1192.
21. Madrid L.V., Wang C.Y., Guttridge D.C., Schottelius A.J., Baldwin A.S., Mayo M.W. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 2000, 20:1626-1638.
22. Maiuri M.C., Tajana G., Iuvone T., De Stefano D., Mele G., Ribecco M.T., Cinelli M.P., Romano M.F., Turco M.C., Carnuccio R. Nuclear factor-kappaB regulates inflammatory cell apoptosis and phagocytosis in rat carrageenin-sponge implant model. Am J Pathol 2004, 165:115-126.
23. Marini A.M., Jiang X., Wu X., Tian F., Zhu D., Okagaki P., Lipsky R.H. Role of brain-derived neurotrophic factor and NF-kappaB in neuronal plasticity and survival: from genes to phenotype. Restor Neurol Neurosci 2004, 22:121-130.
24. Marumo T., Schini-Kerth V.B., Busse R. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes 1999, 48:1131-1138.
25. Mattson M.P., Rychlik B., Chu C., Christakos S. Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons. Neuron 1991, 6:41-51.
26. Pantoni L., Rossi R., Inzitari D., Bianchi C., Beneke M., Erkinjuntti T., Wallin A. Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the scandinavian multi-infarct dementia trial. J Neurol Sci 2000, 175:124-134.
27. Phillips R.G., Meier T.J., Giuli L.C., McLaughlin J.R., Ho D.Y., Sapolsky R.M. Calbindin D28K gene transfer via herpes simplex virus amplicon vector decreases hippocampal damage in vivo following neurotoxic insults. J Neurochem 1999, 73:1200-1205.
28. Ries V., Henchcliffe C., Kareva T., Rzhetskaya M., Bland R., During M.J., Kholodilov N., Burke R.E. Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease. Proc Natl Acad Sci U S A 2006, 103:18757-18762.
29. Sheikh M.S., Huang Y. Death receptor activation complexes: it takes two to activate TNF receptor 1. Cell Cycle 2003, 2:550-552.
30. Teismann P., Schwaninger M., Weih F., Ferger B. Nuclear factor-kappaB activation is not involved in a MPTP model of Parkinson's disease. Neuroreport 2001, 12:1049-1053.
31. Testa J.R., Bellacosa A. Akt plays a central role in tumorigenesis. Proc Natl Acad Sci U S A 2001, 98:10983-10985.
32. Timmons S., Coakley M.F., Moloney A.M., O' Neill C. Akt signal transduction dysfunction in Parkinson's disease. Neurosci Lett 2009, 467:30-35.
33. Vandermoere F., El Yazidi-Belkoura I., Adriaenssens E., Lemoine J., Hondermarck H. The antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-kappaB activation induced via interaction between Akt and IkappaB kinase-beta in breast cancer cells. Oncogene 2005, 24:5482-5491.
34. Wang H.J., Cao J.P., Yu J.K., Zhang L.C., Jiang Z.J., Gao D.S. Calbindin-D28K expression induced by glial cell line-derived neurotrophic factor in substantia nigra neurons dependent on PI3K/Akt/NF-kappaB signaling pathway. Eur J Pharmacol 2008, 595:7-12.
35. Yang F.C., Kapur R., King A.J., Tao W., Kim C., Borneo J., Breese R., Marshall M., Dinauer M.C., Williams D.A. Rac2 stimulates Akt activation affecting BAD/Bcl-XL expression while mediating survival and actin function in primary mast cells. Immunity 2000, 12:557-568.
36. Yin Y.X., Sun Z.P., Huang S.H., Zhao L., Geng Z., Chen Z.Y. RanBPM contributes to TrkB signaling and regulates brain-derived neurotrophic factor-induced neuronal morphogenesis and suivival. J Neurochem 2010, 114:110-121.